Summary
RWS announced the public preview of its Tridion agentic platform on 16 September for medtech, pharmaceutical and manufacturing documentation workflows. The platform connects external changes to governed content, maintains audit trails and keeps publication decisions with people; RWS says early users cut impact-assessment time from days to hours.
Why it matters
This is a practical model for deploying agents in regulated environments, where evidence, version control and human approval are part of the workflow rather than post-launch safeguards.
Related coverage
- Spain reports its first notified breach allegedly executed by an AI agent
- Cohere and Aleph Alpha sign definitive transatlantic sovereign-AI deal
- AI becomes a mainstream shopping channel in new consumer study